Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

317 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes.
Gómez-Isla T, Wasco W, Pettingell WP, Gurubhagavatula S, Schmidt SD, Jondro PD, McNamara M, Rodes LA, DiBlasi T, Growdon WB, Seubert P, Schenk D, Growdon JH, Hyman BT, Tanzi RE. Gómez-Isla T, et al. Among authors: growdon wb, growdon jh. Ann Neurol. 1997 Jun;41(6):809-13. doi: 10.1002/ana.410410618. Ann Neurol. 1997. PMID: 9189043
Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.
Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM. Hock C, et al. Among authors: growdon jh. Ann N Y Acad Sci. 2000;920:285-91. doi: 10.1111/j.1749-6632.2000.tb06937.x. Ann N Y Acad Sci. 2000. PMID: 11193166 Clinical Trial.
Increased blood mercury levels in patients with Alzheimer's disease.
Hock C, Drasch G, Golombowski S, Müller-Spahn F, Willershausen-Zönnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM. Hock C, et al. Among authors: growdon jh. J Neural Transm (Vienna). 1998;105(1):59-68. doi: 10.1007/s007020050038. J Neural Transm (Vienna). 1998. PMID: 9588761
317 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page